abstract |
The present invention provides mild ultrafiltration and sodium that is experienced by peritoneal dialysis patients, including atrial sodium excretory peptides (ANPs), derivatives of ANP, analogs of ANP, substances that bind ANP to elimination receptors, or substances that promote ANP synthesis. Providing a peritoneal dialysis solution causing an increase in clearance. |